DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
NovoCare Direct is the manufacturer cash-pay channel for Wegovy. $499/mo flat, regardless of dose. Cheapest predictable cash-pay route for Wegovy.
Direct-to-patient through Truepill and other fulfillment partners. Wegovy ships in original-brand packaging. 28-day or 30-day fills.
NovoCare Direct: $499/mo cash-pay starting March 2024. No insurance required. Requires US prescription. Does not accept insurance (unsurprisingly).
Novo Nordisk allocates manufacturer-direct supply preferentially. NovoCare fills have been consistent since the May 2026 shortage resolution.
Not applicable — cash-pay only. If you have commercial insurance, your copay through retail may be cheaper than NovoCare; check first.
Uninsured patients, patients with insurance that excludes Wegovy, or anyone wanting price predictability without PA friction.
NovoCare Direct is the gold standard for Wegovy cash-pay. The $499 price is well below retail and competitive with telehealth-channel compounded semaglutide (which is fading).
Editorial summary. Pricing and inventory shift frequently. Confirm with the pharmacy directly before relying on any single source.